Radium-223 for metastatic, castration-resistant prostate cancer: A retrospective chart review study of real-world use in a tertiary hospital in Taiwan-Reference-Cited by-同舟云学术

Radium-223 for metastatic, castration-resistant prostate cancer: A retrospective chart review study of real-world use in a tertiary hospital in Taiwan

Published:2022-10 Issue:10 Volume:121 Page:1929-1937
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Weng Wei-Chun,Huang Li-Hua,Tseng Neng-Chuan^ORCID,Ou Yen-Chuan

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Bubendorf;Hum Pathol,2000

2. Clinical features of metastatic bone disease and risk of skeletal morbidity;Coleman;Clin Cancer Res,2006

3. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer;Weinfurt;Ann Oncol,2005

4. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer;DePuy;Support Care Cancer,2007

5. ESMO guidelines committee. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Parker;Ann Oncol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world safety and effectiveness of radium‐223 in patients with metastatic castration‐resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study;International Journal of Cancer;2024-06-26

2. Survival outcomes of radium-223 therapy for metastatic castration-resistant prostate cancer following national health insurance reimbursement in Taiwan;Journal of the Chinese Medical Association;2024-05-21

3. Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study;Cancers;2023-07-06

4. Treatment outcomes with radium-223 in docetaxel-naïve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: Real-world evidence from Taiwan;Medicine;2023-02-03

5. Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials;Discover Oncology;2022-10-18